Trial record 99 of 350 for:
Gastrointestinal Stromal Tumors
Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure (LENVAGIST)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04193553 |
|
Recruitment Status :
Recruiting
First Posted : December 10, 2019
Last Update Posted : March 29, 2023
|
Sponsor:
Centre Leon Berard
Information provided by (Responsible Party):
Centre Leon Berard
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2023 |
| Estimated Study Completion Date : | September 2024 |